ISSN 1612-3352

Editors in Chief

Prof. Dr. Claus F. Claussen, Neurootological Research Institute of the Research Society for Smell, Taste, Hearing and Equilibrium Disorders at Bad Kissingen (4-G-F). Bad Kissingen, Germany.
Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Production Managers

Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.


Associated Editors


The editors welcome authors to submit articles for publications in the ASN.

Read the Information for Authors.


Kurhausstraße 12
D-97688 Bad Kissingen
Germany
Telefon +49-971-6 4832
Fax +49- 971- 6 8637
Email asn@neurootology.org

 

Archived under the topic

Neurootology

Intratympanic dexamethasone treatment for control of subjective idiopathic tinnitus: our clinical experience

In this report, we summarize our clinical experience with intratympanic dexamethasone treatment (IDT) for control of tinnitus.


Cognitive disorders: diagnosis and treatment

During the last half century, medical developments have expedited an increase of expectation of life, all over the world. This extension of life has made that some pathologies that in former years were considered of low prevalence, nowadays they have become top priority for public health.


Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of ménière’s disease: a rando

In a randomized, double-blind clinical study, we evaluated the efficacy and tolerability of the fixed combination of cinnarizine, 20 mg, and dimenhydrinate, 40 mg (Arlevert [ARL]) in comparison to betahistine dimesylate (12 mg) in 82 patients suffering from Ménière’s disease for at least 3 months and showing the characteristic triad of symptoms (paroxysmal vertigo attacks, […]


Homage to prof. dr. bernhard hofferberth

It is a great privilege for me and my wife Julia, having been appointed to honour Prof. Dr. Bernhard Hofferberth, to whom we are friendly bound since 25 years ago, both in the scientific and personal field.


Doppler ultrasonography in tinnitus patients

Tinnitus can be functionally measured and localized through sensorimotor and neurosensory tests. According to our Neurofisiología Otooftalmológica data bank, 60% of patients requiring a consultation have a history of cardiocirculatory disorders. This figure has moved us to study cerebrovascular processes in those patients seeking consultation for a tinnitus symptom only. The sudden appearance of the […]


Response of human skull to bone-conducted sound in the audiometric-ultrasonic range

Some new therapies for tinnitus employ bone-conducted sound in the high audio and ultrasonic frequencies, but there has been little previous research on sound transmission through the head at these frequencies.


Vertigo as a prognostic sign in sudden sensorineural hearing loss

Several prognostic indicators of favorable outcome in idiopathic sudden sensorineural hearing loss (ISSHL) have been proposed: an initial profound hearing loss, a down-sloping audiometric curve, advanced age, and the presence of vertigo. The latter has been disputed in the literature. The present study addressed the correlation between vertigo and outcome of ISSHL. Sixty-seven patients with […]


The early kinetics of gentamicin uptake into the inner ear

Transtympanic gentamicin administration has become a popular modality in the treatment of Ménière’s disease. This modality and other inner-ear medical therapy are gaining increased clinical and scientific attention.


A new therapeutic procedure for treatment of objective venous pulsatile tinnitus

Pulsatile tinnitus usually means a turbulent flow within the vessels. We describe a 54-year-old man with a disabling objective pulsatile tinnitus due to a diverticulum of the sigmoid sinus toward the ipsilateral mastoid. We performed a surgical intervention via the endovascular route using coils to obliterate the diverticulum and a stent to avoid coil migration. […]


Gaba – benzodiazepine – chloride receptor – targeted therapy for tinnitus control: preliminary report

Our goal was to attempt to establish neuropharmacological tinnitus control (i.e., relief) with medication directed to restoration of a deficiency in the g-aminobutyric acid – benzodiazepine – chloride receptor in tinnitus patients with a diagnosis of a predominantly central type tinnitus.


Login

Registration

If you are not already registered, please register here for free.

If you are registered but have forgotten your password (or you never had one), click here to recover your password.

Proceedings of

Authors

Archives

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |

(bi)gital»